Finally, we selected the most commonly upregulated target in A549 (3.02 Log2FC) and H1755 (5.74 Log2FC), namely the SPP1/Osteopontin, whose expression was correlated to poor survival in patients with lung adenocarcinoma (LUAD) (Figure 7E). Here, SPP1 is linked to lung adenocarcinoma.